Structure

InChI Key RSEPBGGWRJCQGY-RBRWEJTLSA-N
Smile CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C
InChI
InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C23H32O3
Molecular Weight 356.51
AlogP 5.35
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 4.0
Polar Surface Area 46.53
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 26.0

Pharmacology

Action Mechanism of Action Reference
AGONIST Estrogen receptor alpha agonist DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Menopause 4 D008593 ClinicalTrials
Metrorrhagia 3 D008796 ClinicalTrials
Atrophic Vaginitis 3 D059268 ClinicalTrials
Dysmenorrhea 3 D004412 ClinicalTrials
Infertility 3 D007246 ClinicalTrials

Related Entries

Scaffolds

Parent
Mixture
Mixture
Mixture

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Nervous system disorders
18.26
General disorders and administration site conditions
13.45
Injury, poisoning and procedural complications
8.96
Psychiatric disorders
7.75
Skin and subcutaneous tissue disorders
6.95
Vascular disorders
5.39
Investigations
5.01
Pregnancy, puerperium and perinatal conditions
4.94
Reproductive system and breast disorders
4.01
Musculoskeletal and connective tissue disorders
3.22
Gastrointestinal disorders
3.18
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
2.97
Product issues
2.9
Cardiac disorders
2.35
Eye disorders
2.35

Cross References

Resources Reference
CAS NUMBER 979-32-8
ChEBI 31561
ChEMBL CHEMBL1511
DrugBank DB13956
DrugCentral 1064
EPA CompTox DTXSID8023004
FDA SRS OKG364O896
Guide to Pharmacology 7655
KEGG C12859
PubChem 13791
SureChEMBL SCHEMBL40563
ZINC ZINC000003881556